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Purpose: The purpose of this study was to report our results in the surgical management 
of recurrent carotid stenosis (RCS) after carotid endarterectomy (CEA). 
Methods: In a 20-year period, we performed 1209 CEAs; 82 operations (6.8%) were for 
RCS. There were 33 men and 36 women, with an average age of 66.3 years. Nine patients 
underwent wo redo CEAs and two patients underwent hree redo CEAs for either 
bilateral recurrence or a second recurrence on the same side. Overall, 10 patients were 
identified with a second recurrence. 
Results: The average time to presentation with RCS was 65 months (range, 3 to 361 
months). The majority of patients (66%) were symptomatic, 34% had transient ischemic 
attacks, 17% had amaurosis fugax, 9% had strokes, and 6% had nonhemispheric symp- 
toms. Before repair, angiograms were obtained. Patch repair was performed in 61 
procedures (74%), 41 with vein, 11 with Dacron, and nine with polytetrafluoroethylene. 
Autogenous or synthetic bypass grafts were used in 20 procedures (24%), vein in eight, 
Dacron in two, and polytetrafluoroethylene in 10. In one patient, an occluded internal 
carotid artery was ligated and an endarterectomy of the external carotid artery was 
performed without a patch. The operative stroke rate was 4.8%. Minor complications 
included transient or permanent cranial nerve deficits in 7.3% and wound hematomas in
2.4%. 
Conclusion: Although repeat endarterectomy to treat RCS is technically more demanding, 
it can be performed safely. Long-term follow-up examination shows that a second 
recurrence may develop, and we recommend serial noninvasive testing. (J Vasc Surg 
1997;25:877-83.) 
Carotid endarterectomy (CEA) is an effective op- 
eration designed to prevent stroke. Several large mul- 
ticenter studies have demonstrated that endarterec- 
tomy is superior to the best medical management of
high-grade symptomatic or asymptomatic carotid 
stenosis. 1-3 Long-term follow-up studies indicate 
that recurrent postoperative carotid stenosis (RCS), 
including residual stenosis not repaired at the time of 
operation, can be expected in 1.2% to 36% of pa- 
tients .4,5 
I f  residual stenosis resulting from a technically 
inadequate operation is excluded, there are two pat- 
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terns of recurrence, early and late. Early recurrences 
that are detected within the first 2 years are usually 
the result of  myointimal hyperplasia nd appear less 
likely to cause symptoms when compared with late 
lesions that are the result of recurrent atherosclero- 
sis. 6 Most surgeons would recommend reoperation 
for symptomatic recurrent lesions; however, there is 
some controversy regarding asymptomatic lesions. 7
In this overview, we report our operative results 
in the management of recurrent carotid stenosis and 
the long-term follow-up after reoperation. 
PAT IENTS AND METHODS 
Patient selection. In a 20-year period ending in
August 1996, 1209 CEAs were performed in 408 
women and 626 men by the attending vascular sur- 
geons in the Peripheral Vascular Surgery Division at 
Loyola University Medical Center. Patients who uu- 
derwent a repeat CEA (RCEA) for RCS that oc- 
curred at least 3 months after an initial CEA were 
identified from the cerebrovascular registry. The hos- 
pital charts, outpatient and office records were re- 
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Table I. Patient characteristics and 
risk factors 
Characteristic No. (%) 
Age (yr) 66.3 _+ 7.7 
Sex 
Men 33 
Women 36 
Risk factors 
Hypertension 
Diabetes 
CAD-MI 
PVD 
Smoking 
Hyperlipidemia 
Aspirin/ticlid 
Previous troke 
59 (86) 
16 (23) 
36 (52) 
35 (5~) 
41 (59) 
41 (59) 
39 (57) 
9(13) 
CAD, Coronary artery disease; M/, myocardial infarction; PVD, 
peripheral vascular disease. 
viewed, as well as the initial and follow-up noninva- 
sive carotid studies that were performed in our 
accredited noninvasive vascular laboratory. 
Noninvasive investigation. In 1983 we began 
to use duplex scanning, and currently carotid color- 
flow duplex scanning is performed with one of twO 
ATL instruments (model HDI  3000; Advanced 
Technology Laboratories, Bothell, Wash.). In 1986 
we started routine intraoperative completion duplex 
scanning after CEA. sOur current surveillance proto- 
col includes a color-flow duplex scan before dis- 
charging the patient from the hospital, at 6 months, 
and then yearly thereafter. When a stenosis is de- 
tected after surgery in an asymptomatic patient, repeat 
noninvasive studies areperformed on a more frequent 
basis at the discretion of the attending vascular surgeon. 
In our laboratory, a hemodynamically significant steno- 
sis (>75% area stenosis) correlates with a peak systolic 
velocity greater than 250 cm/sec. A cerebral angio- 
gram is obtaincd before surgery to confirm the pres- 
ence, location, and extent of the RCS. 
Statistical analysis. Life-table analysis was used 
to determine cumulative stroke and recurrence-free 
survival rates for patients who underwent a RCEA. 
RESULTS 
During the study period, a total of 82 CEAs 
(6.8%) were performed for recurrent carotid stenosis; 
10 of those (12%) were for a second recurrence. 
Patient characteristics and risk factors are outlined in 
Table I. The original CEA was performed at another 
hospital in 36 arteries (44%). The primary endarter- 
ectomy was closed with a patch angioplasty in eight 
women, four with Dacron and four with vein, and in 
one man with Dacron. 
Table II. Operations and graft material used 
No. of procedures 82 
Side 
Left 45 
Right 37 
Type of repair 
Patch with 
Vein 41 
Dacron 11 
PTFE 9 
Graft with 
Vein 8 
Dacron 2 
PTFE 10 
External CEA without patch 1 
Symptoms. Symptoms developed in 54 patients 
(66%): transient ischemic attacks (TIAs) in 28 (34%), 
amaurosis fugax in 14 (17%), stroke in seven (9%), 
and nonhemispheric symptoms in five (6%). There 
were seven patients (9%) who had a stroke as their 
first symptom, and they were found to have a stenosis 
ranging from 50% to 99%. There were 28 patients 
(34%) who were asymptomatic. Preoperative anglo- 
grams confirmed the presence of a high-grade RCS 
in 79 vessels, and in the remaining three internal 
carotid artery (ICA) occlusion and high-grade xter- 
nal carotid artery (ECA) stenosis was suggested. 
Contralateral occlusion was present in 26 patients 
(32%). 
Operative procedures. CEA was performed 
with the patient under normocarbic, normotensive 
general anesthesia. Intraoperative electroencephalo- 
graphic monitoring was rarely used. The operative 
technique of RCEA has been described else- 
where. 9,1° Early recurrent stenoscs that result from 
myointimal hyperplasia were difficult to extract by 
means of a standard endarterectomy because the 
lesion was well adherent and the normal cleavage 
planes were absent. These lesions were usually 
repaired with the use of autogenous or synthetic 
patch angioplasty. In 20 procedures, resection of the 
abnormal vessel with common carotid artery-to- 
ICA bypass grafting was performed using autoge- 
nous reversed saphenous vein or polytetrafluoroeth- 
ylene (PTFE) graft. Late recurrences that resulted 
from atherosclerosis were treated with a standard 
CEA and patch angioplasty closure, with either au- 
togenous vein, Dacron or PTFE (Table II). 
In three cases, ICA occlusion was confirmed at 
operation. Ligation of the ICA was performed in 
conjunction with ECA endarterectomy to a,old dis- 
tal embolization from the carotid stump through the 
ECA, and two f these patients ubsequently under- 
went an extracranial-intracranial bypass procedure. 
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Table I I I .  Characteristics and symptoms of patients undergoing a second redo CEA 
Age No. of risk Contralateral Time to 
Patient (yr) Sex Side factors Symptoms side Operation reccurence (too) 
1 71 M R 3 TIA 100% Dacron graft* 13 
2 61 M L 4 CVA 95% Vein graft 36 
3 70 M R 4 AF patent PTFE graft 74 
4 68 M L 6 AF patent External CEA & 112]" 
ICA ligation 
5 71 F L 4 None 50% PTFE patch 107 
6 76 F R 2 TIA 100% PTFE graft 3 
7 67 M L 5 TIA/AF 100% PTFE graft 6 
8 70 F R 3 TIA 30% PTFE graft 24 
9 57 M R 4 AF 100% Vein patch 11 
10 65 F L 4 AF 20% Vein graft 36 
*Right subclavian-carotid artery bypass with redo CEA. 
}Occluded at 12 months, became symptomatic requiring second redo external CEA and ICA ligation at 112 months. 
CVA, Cerebrovascular ccident; AF, amaurosis fugax. 
In three other cases, RCEA was performed in combi- 
nation with another procedure. One patient under- 
went right subclavian artery-to- carotid artery bypass 
procedure, one underwent an aorta-to-left carotid 
artery and left subclavian artery bypass procedure 
with a bifurcated Dacron graft, and the third patient 
underwent an aorta-coronary artery bypass proce- 
dure. Indwelling shunts were used in 16 operations 
(19.5%) on the basis of measured carotid back pres- 
sure, and intraoperative duplex scanning was per- 
formed after 21 CEAs (26%). The majority of our 
RCEAs was performed before we began to use intra- 
operative duplex scanning routinely. Table II shows 
the graft materials and techniques used for RCEAs. 
Pathologic findings. We previously reported a 
detailed study on the microscopic appearance and 
immunocytochemical assays of lesions as a result of 
recurrent carotid stenosis, n In some operations, es- 
pecially for myointimal hyperplasia, there were no 
specimens to submit. Of  the 47 specimens submitted 
for pathologic examination, five showed myointimal 
hyperplasia nd two had a combination of myointi- 
real hyperplasia nd atherosclerosis. All seven hyper- 
plastic recurrences were within 2 years (range, 3 to 
23 months). In 10 of the 40 recurrences that showed 
only atherosclerotic changes, the time of recurrence 
was also within 2 years (range, 6 to 19 months). In all 
others, RCS occurred at 25 months or later. 
Onset and site o f  recurrence. The average time 
for the development of RCS was 65 months (range, 
3 to 361 months). There were 28 lesions that devel- 
oped in the first year after CEA, and two of those 
recurred in less than 6 months. In one case, a post- 
operative noninvasive study on the first day after the 
operation showed no evidence of residual stenosis, 
and recurrent disease was detected at 3 months. In 
the other case, increased frequencies were present 1 
day after redo operation with a vein graft; the patient 
had a TIA 3 months after surgery and underwent a 
second RCEA. Recurrence was diagnosed after 5 
years from the initial CEA in 31 vessels. Seven pa- 
tients were treated for bilateral recurrent lesions. A 
second recurrence on the same side occurred in six 
instances, two of which were in patients who had 
bilateral RCS. Overall, there were 10 operations (in 
nine patients) that were performed for a second re- 
currence. The clinical details of secondary recurrence 
are outlined in Table III. 
Complications. There were two angiographic 
complications. One patient had a stroke, and another 
patient had acute right arm ischemia after cerebral 
angiographic examination performed through an ax- 
illary approach. The latter patient underwent emer- 
gent axillary thrombectomy and repair 2 days before 
RCEA. Intraoperative duplex scanning detected an 
intimal flap in one case and a frond in another. Both 
vessels were immediately reexplored with no adverse 
neurologic sequelae. Two other patients (2.4%) in 
whom a cervical hematoma developed in the recov- 
ery room were returned for immediate xploration 
and evacuation of the hematoma. Two patients had a 
perioperative myocardial infarction, and in one pa- 
tient an urgent aorta--coronary artery bypass proce- 
dure was required. Transient or permanent cranial 
nerve deficits occurred after six RCEAs (7.3%). 
There were four transient hypoglossal, one marginal 
mandibular, and one permanent vagal paresis. Tran- 
sient Homer's syndrome developed in one patient. 
Four patients awoke with a stroke (4.8%), and one of 
them made a good recovery with no residual deficit. 
In two patients, immediate reexploration confirmed 
patency of the artery, and one underwent a duplex 
scan that showed that the ICA was patent. In one 
patient, stroke developed after external CEA and 
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Fig. 1. Cumulative survival rates without RCS or stroke. See Table IV for standard errors. 
Table IV. Ipsilateral restenosis-ffee rate 
Interval 
Nonstroke deaths 
No. at No. of + No. surviving No. lost to 
risk restenosis incomplete int rval follow-up Interval (%) Cumulative (%) SE (%) 
1 month 72 1 3 3 98.6 98.6 1.4 
6 months 65 3 1 0 95.4 94.0 2.9 
1 year 61 0 5 0 100.0 94.0 2.9 
2 years 56 1 2 0 98.2 92,3 3.3 
3 years 53 0 10 3 100.0 92,3 3.3 
4 years 40 0 8 0 100.0 92.3 3.3 
5 years 32 0 30 2 100.0 92.3 3.3 
ICA ligation. This patient had a >90% stenosis of the 
ECA proximal to an extracranial-intracranial bypass. 
One patient had a postoperative TIA, and one had 
an isolated episode of  amaurosis fugax with no 
further sequelae. Minor complications occurred in 
another two patients; one had bronchitis and one 
had a urinary tract infection. There were no 
deaths. 
Life table. Long-term follow-up examination 
on the group of 72 arteries that underwent RCEA 
disclosed a92.3% stroke-free and restenosis-free rate 
at 5 years (Table W; Fig. 1). 
D ISCUSSION 
CEA is a durable operation that provides freedom 
from stroke in the vast majority of patients. 12 Even 
when technically incomplete operations are ex- 
cluded, restenosis may occur at the endarterectomy 
site. Since the widespread introduction of duplex 
scans, many follow-up studies have been published 
that established the RCS rate as ranging fro m 1.2% to 
36%. 4-7,9,13-19 The actual clinically important inci- 
dence averages about 10%, and in large surgical series 
only about 5% of the total number of CEAs require a 
redo operation (Table V). In this series, 6.8% of our' 
CEAs were for redos; however, if we exclude the 36 
patients who underwent their initial CEA elsewhere, 
our incidence is only 3.8%. 
The frequency of postoperative noninvasive stud- 
ies varies among investigators. The goal of surveil- 
lance is to detect a hcmodynamically significant ste- 
nosis before it progresses to complete occlusion. 
Before the availability of duplex scans, Javid et al. 2° 
observed patients with carotid stenosis with angiog- 
raphy. They discovered recurrent carotid disease after 
CEA in seven patients; four had complete occlusion 
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Table V. Summary of reports on management of recurrent stenosis 
Second Operative Cranial nerve 
Reference n Incidence Symptomatic restenosis stroke Death injury 
Das et al. 198626 65 3.8% 51% NR 1.5% 3.1% 9.2% 
Piepgras et al. 198619 57 NR NR NR 10.5% 0 NR 
Bartlett et al. 19879 116 NR 70% 5.8% 4.3% 1.7% 17% 
Kazmers et al. 198818 14 1.3% 100% NR 0 0 14% 
Treiman et al. 199222 162 NR 93% 12.3% 2.4% 0.6% 2.4% 
AbuRahma et al. 1994 I7 46 5% 72% 2% 7% 0 6.5% 
Coyle et al. 199516 69 6.4% 54% Nt~ 1.4% 2.9% NR 
Raithel, 199623 66 1.1% 77% 1.5% 3.1% 0 4.7% 
O'Donnel l  et aL 199613 48 NR 67% NR 2.1% 2.1% 18.9% 
Mansour et al. 1997 82 3.8%* 66% 12.2% 4.8% 0 7.3% 
NR, Not reported. 
* Excluding patients who underwent their first operation elsewhere. 
and three had a high-grade stenosis. In a more recent 
study using duplex scanning, Mattos et alJ 4 found that 
>50% RCS occurred in 10.8% of their patients who 
underwent CEA, and 70.5% of those restenoses were 
detected in the first 2 years. They also fomad that RCS 
was more common in women and in patients who did 
not undergo patch angioplasty at the time of CEA. 
Other investigators eported similar findings. 21 In our 
group of patients with RCS, more women (8.8%) than 
men (5.2%) required a redo operation. This observed 
difference is significant (p = 0.029, Fisher's exact est), 
but it should be emphasized that only 66% of the 
original CEAs were performed at our institution. The 
likely explanation is that women may indeed have a 
higher ate of restenosis that becomes ymptomatic or
requires reoperation. 
In this report, we did not investigate the fate of 
unoperated recurrent carotid stenosis. Cook et al.7 
found an incidence of RCS of  18.4% of their CEAs. 
Long-term follow-up of these patients disclosed that 
71.4% of the lesions remained stable, whereas 28.6% 
regressed. In 12 of 14 patients the lesions of RCS 
remained asymptomatic, and the two remaining pa- 
tients had TIAs. They also noted that patients in 
whom asympt()matic RCS developed were not at a 
higher risk of neurologic problems when compared 
with patients who did not have RCS. 
Stoney and String 6 were first to describe the two 
patterns of RCS, early stenosis that results from my- 
ointimal hyperplasia nd late stenosis that results 
from recurrent a herosclerosis. Other authors have 
reported similar observations. 4,11,z2 Myointimal hy- 
perplastic lesions differ from recurrent a herosclerosis 
in other respects. At operation, myointimal hyperpla- 
sia appears as a smooth, firmly adherent localized 
thickening at the site of previous endarterectomy, 
whereas atherosclerotic lesions tend to be irregular, 
friable, and subject o endarterectomy. 6 Because the 
late recurrent lesions are atherosclerotic and occa- 
sionally ulcerated, they tend to give rise to symptoms 
in the carotid territory. 
There is a consensus among vascular surgeons 
that hemodynamically significant RCS that produce 
hemispheric symptoms should be repaired. In a re- 
cent meta-analysis, O'Donnell et al. 13 found that 
70.4% of operations were performed for symptom- 
atic RCS. We agree with this approach and fotmd 
that the majority of our patients (66%) were symp- 
tomatic. There is still controversy regarding the most 
appropriate management ofasymptomatic RCS. The 
rationale for treating asymptomatic RCS is to prevent 
a devastating stroke that might accompany disease 
progression to total occlusion. O'Donnell et al. 13 
found a higher stroke rate in patients with asymptorn- 
atic RCS who did not undergo operation (7.5% vs 
2.1%) and suggested a more aggressive surgical ap- 
proach. On the other hand, a more conservative non- 
operative approach as been advocated by Cook et al.7 
and Washburn et aljs because they found that RCS 
tends to run a benign course in their patients. We favor 
a surgical approach in asymptomatic patients with RCS 
who have a contralateral occlusion or who, on postop- 
erative noninvasive studies, show evidence of rapid pro- 
gression to a significant stenosis. 
The surgical approach to RCS differs from pri- 
mary endarterectomy. Although others have used 
regional anesthesia, we have preferred using general 
anesthesia for all our procedures. 4 In most series that 
have addressed the management of RCS, closure of 
the arteriotomy was performed with either a vein ,or 
synthetic patch angioplasty. Treiman et al. 22 used 
resection and autogenous grafting for recurrent le- 
sions and advocated the use of this technique instead 
of redo endarterectomy with vein patching. They 
had four graft occlusions in their series, and two were 
symptomatic. Raithel prefers the use of  PTFE for 'all 
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redos and reports favorable results with this tech- 
nique. 23 Early in our experience, we used vein patch 
or grafts for recurrent lesions. Two of our vein grafts 
thrombosed in the follow-up period at 5 and 9 
months. In the last 4 years, we have preferentially 
used PTFE replacement grafts, especially when ex- 
tensive scarring is encountered around the old end- 
arterectomy site or when the patient has a secondary 
recurrence. None of the PTFE grafts thrombosed, 
and only one developed RCS at 23 months. This 
stenosis, detected by duplex scanning, was initially 
asymptomatic; however, 1 month later the patient 
had a TIA. At operation, myointimal hyperplasia was 
present near the proximal graft anastomosis. 
Secondary recurrence may occur after redo end- 
arterectomy. Callow and Mackey ~2 found that 3.4% 
of all CEAs were for a second recurrence. Gagne et 
al. 4 and Treiman et al. 22 also had a significant num- 
ber of tertiary operations. More recently, Rosenthal 
et al. 24 surveyed the membership of the Southern 
Association for Vascular Surgery and reported on 31 
patients who had secondary RCS. The majority of 
patients (65%) returned with recurrent symptoms at 
an average time of 39.8 months after their first redo 
operation. They found that all their patients had at 
least three risk factors present and that 74% were 
female smokers. In our series, a second redo was per- 
formed in nine patients (10 CEAs), and one patient 
underwent bilateral RCEAs. Symptomatic RCS was 
present in 90% of CEAs, and the only asymptomatic 
patient had a 90% ipsilateral stenosis and a moderate 
contralateral stenosis. We also noted that eight of nine 
patients had three or more risk factors (Table III). 
Redo operations have an acceptable perioperative 
stroke and mortality rate (Table V). The incidence of 
transient cranial nerve deficits appears to be some- 
what higher than that after primary CEA. There were 
no perioperative deaths in this series, and the stroke 
rate was 4.8%. Since 1986 we have performed rou- 
tine intraoperative duplex scanning after CEA. s Re- 
sidual defects or technical imperfections can be cor- 
rected before leaving the operating room. We also 
supplement this study with another one before the 
patient's discharge from the hospital. Carballo et al.5 
found a 19% incidence of postoperative RCS in pa- 
tients who had residual defects compared with a 5.6% 
rate of RCS in patients who had normal scans. 
In this era of cost-containment, our management 
of patients who undergo CEA has evolved. There is 
now greater emphasis on selective intensive care unit 
admissions and decreasing hospital ength of stay. 25 
Although cerebral angiograms are not always ob- 
tained before primary CEA, we have not routinely 
operated on a recurrent carotid stenosis without an 
angiogram. Scheduled postoperative carotid surveil- 
lance at regular intervals is important 26 because iden- 
tification of asymptomatic RCS may precede the ap- 
pearance of symptoms. In 14 of our last 19 cases, 
RCS was initially discovered on a routine surveillance 
scan. Follow-up after the secondary operation is also 
important for the same reason. 2 
CONCLUSION 
Recurrent carotid stenosis is a recognized com- 
plication of CEA. Recurrent symptomatic lesions can 
be repaired with an acceptable stroke and mortality 
rate. Long-term follow-up with duplex scanning is 
necessary after redo carotid surgery because tertiary 
stenosis can occur. 
We thank Pam Jahoda for her assistance in data storage 
and compilation. 
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DISCUSSION 
Dr. Ralph C. Whalen (Toledo, Ohio). I must say that 
I agree fully with the conclusions that were found in this 
presentation. I have only a couple of questions with respect 
to the study. One of the statements hat was made in the 
presentation referred to the safety of redo operations. Un- 
fortunately, in this series there was a 4.8% incidence of 
operative stroke. We reviewed our own series at the Jobst 
Vascular Center by reviewing the registry. In the previous 
4 years, we performed 655 CEAs and seven strokes re- 
sulted, for an operative stroke risk of about 1.2%. In that 
group there were only 40 redo procedures, which is about 
half the size of this group. We had zero strokes, and I am 
concerned that there is a substantial difference between the 
4.8% that you had and 0% that we had in our own series. 
My suspicion is that the 4.8% is also much higher than your 
incidence of stroke for primary CEAs. The type of repair I
found somewhat curious, in that 70% of your repairs were 
made by bypass grafting rather than endarterectomy and 
patch angioplasty. In our own series, it was about the 
opposite distribution. You did also end up with about a 
12% incidence of recurrence on the redo operations, which 
is about three times what you had on the original series. I
am wondering whether the type of repair or the type of 
material might be related to that. In the primary-type 
repair of CEA, there have been studies that have suggested 
that a reduced incidence of RCS is associated with patch 
repair, and this statement does not seem to hold true in 
your series. I think that the discussion was absolutely excel- 
lent in this paper, and I think that we should really empha- 
size the discussion and reading of this as it becomes pub- 
lished later on. 
Dr. M. AshrafMansour .  Our stroke rate for primary 
CEAs is lower than 2%. The stroke rate in this study was 
4.8%, and as you noted one of the patients had a stroke as a 
result of the angiographic examination. One of the other 
patients who had a stroke had a complete ICA occlusion, 
and she had a stroke when an external CEA was performed 
to prevent embolization from the stump; she had a patent 
extracranial-intracranial bypass graft, and we think that she 
might have embolized at the time of the endarterectomy. I 
don't  think any of the strokes were preventable, in looldng 
back at the charts. I want to emphasize that the slide in the 
presentation might have been confusing-we used endarter- 
ectomy and patch angioplasty in 61 of the 82 recurrent 
operations, and we used graft in only 20. There was one 
patient who did not receive a patch or graft and that was a 
patient who underwent the external CEA with ICA liga- 
tion. So the message is: if the recurrence occurs after 2 
years and it's recurrent carotid atherosderosis, then a 
RCEA can be performed, and we advocate the use of a 
patch at that time. However, if there is a lot of scarring and 
you cannot safely dissect out the recurrent disease in the 
ICA, then a bypass procedure may be safer to perform, 
from the common carotid artery to the distal ICA. 
